Antibiotic Resistance in 2020
Cassandra Kuhn
Abstract
Antibiotic resistance has become a growing issue in the past decade. With more and more bacteria becoming increasingly resistant, healthcare workers are finding it more and more difficult to treat certain bacterial resistant infections. Several factors contribute to this issue which may include a lack of profitability of antibiotics and lack of new mechanisms of action being discovered. The FDA and WHO are attempting to combat this problem, but despite their efforts, there are still too few new novel antibiotics. With COVID-19 emerging in the last year, the uncertainty around increasing antibiotic resistance has grown even more.
Full Text
volume5article1.pdf
File Size: 658 kb
File Type: pdf
Download File

Notice and Disclaimer

Medicine is an ever-changing science.  As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required.  The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.  However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work.    Readers are encouraged to confirm the information contained herein with other sources.   For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.

Subscribe to ARxCH